Yanan Bicon Pharmaceutical Listed Company Posted 166.6 Million Yuan Net Loss in First Quarter of 2023

Yanan Bicon Pharmaceutical Listed Company (延安必康制药股份有限公司) (002411.SZ) reported a net loss of 166.6 million yuan in the first quarter of 2023, reversing a net profit of 325 million yuan for the same period in the previous year.

Meanwhile, the company posted 1.2 billion yuan in revenue, down 46.4% year-on-year.

At the end of the reporting period, it had 14.9 billion yuan in total assets and 8.9 billion yuan in total liabilities, with a liability-to-asset ratio of 59.9%.